Sung-Chul Lim Selected Research

COVID-19

1/2023	Efficacy of Plant-Made Human Recombinant ACE2 against COVID-19 in a Golden Syrian Hamster Model.
1/2022	Eosinophil-mediated lung inflammation associated with elevated natural killer T cell response in COVID-19 patients.
10/2021	Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sung-Chul Lim Research Topics

Disease

48	Neoplasms (Cancer) 02/2022 - 01/2002
14	Breast Neoplasms (Breast Cancer) 08/2023 - 09/2002
13	Necrosis 05/2020 - 05/2007
12	Carcinogenesis 04/2021 - 09/2003
12	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2002
11	Carcinoma (Carcinomatosis) 01/2021 - 09/2002
10	Adenocarcinoma 07/2020 - 01/2002
7	Melanoma (Melanoma, Malignant) 12/2023 - 02/2012
6	Neoplasm Metastasis (Metastasis) 12/2023 - 09/2002
5	Lung Neoplasms (Lung Cancer) 10/2023 - 05/2007
5	Chronic Obstructive Pulmonary Disease (COPD) 09/2023 - 06/2013
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2014 - 03/2005
5	Colorectal Neoplasms (Colorectal Cancer) 07/2013 - 06/2007
5	Lymphatic Metastasis 05/2011 - 09/2002
4	Wounds and Injuries (Trauma) 01/2023 - 07/2004
4	Inflammation (Inflammations) 12/2021 - 04/2010
4	Adenocarcinoma of Lung 03/2013 - 08/2007
4	Squamous Cell Carcinoma of Head and Neck 09/2010 - 09/2003
3	Hemoptysis 01/2023 - 01/2017
3	COVID-19 01/2023 - 10/2021
3	Infections 01/2022 - 01/2016
3	Hepatocellular Carcinoma (Hepatoma) 05/2020 - 03/2006
3	Hypoxia (Hypoxemia) 01/2020 - 03/2011
3	Dyspnea (Shortness of Breath) 01/2017 - 01/2013
3	Pneumonia (Pneumonitis) 06/2016 - 09/2003
3	Rupture 03/2011 - 08/2007
3	Colonic Neoplasms (Colon Cancer) 07/2010 - 10/2007
2	Hemorrhage 01/2023 - 01/2021
2	Tuberculosis (Tuberculoses) 01/2023 - 01/2017
2	Fever (Fevers) 01/2021 - 09/2012
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2005
2	Sarcoidosis (Schaumann Disease) 03/2020 - 07/2017
2	Neutropenia 12/2013 - 08/2012
2	Adenoma (Adenomas) 05/2011 - 01/2005
2	Hyperplasia 04/2011 - 09/2006
2	Body Weight (Weight, Body) 11/2007 - 04/2006
2	Acute Lung Injury 12/2004 - 12/2004
2	Ventilator-Induced Lung Injury 12/2004 - 12/2004

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2005
12	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 05/2007
7	CytokinesIBA 01/2022 - 06/2007
7	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2011 - 05/2007
5	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2020 - 09/2003
5	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 10/2018 - 07/2010
5	HMGB1 Protein (HMG1)IBA 09/2011 - 08/2007
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2010 - 09/2003
4	GoldIBA 09/2023 - 06/2013
4	Phosphotransferases (Kinase)IBA 01/2023 - 05/2007
4	EnzymesIBA 02/2022 - 06/2007
4	Messenger RNA (mRNA)IBA 04/2021 - 01/2002
4	Cisplatin (Platino)FDA LinkGeneric 08/2019 - 04/2010
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017 - 05/2016
4	LigandsIBA 05/2017 - 01/2002
4	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 09/2015 - 04/2010
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2009 - 09/2003
3	LipidsIBA 01/2021 - 05/2011
3	Small Interfering RNA (siRNA)IBA 01/2021 - 03/2011
3	AntigensIBA 01/2021 - 02/2012
3	Docetaxel (Taxotere)FDA Link 11/2014 - 08/2012
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2014 - 10/2007
3	ErbB Receptors (EGF Receptor)IBA 03/2013 - 08/2004
3	Cyclin D1IBA 12/2009 - 09/2002
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 09/2016
2	Fibrinogen (Factor I)FDA Link 01/2023 - 01/2021
2	BatroxobinIBA 01/2023 - 01/2021
2	AcidsIBA 01/2022 - 04/2010
2	MethyltransferasesIBA 12/2021 - 10/2018
2	VimentinIBA 09/2021 - 07/2009
2	Bronchodilator Agents (Bronchodilators)IBA 02/2021 - 07/2020
2	S100 Proteins (S 100 Protein)IBA 07/2020 - 07/2009
2	CateninsIBA 05/2020 - 05/2011
2	Cyclin-Dependent Kinase 8IBA 05/2020 - 05/2011
2	Oxygen (Dioxygen)IBA 01/2020 - 07/2010
2	TNF-Related Apoptosis-Inducing LigandIBA 07/2017 - 05/2016
2	SteroidsIBA 07/2017 - 09/2003
2	Interferon-gamma (Interferon, gamma)IBA 01/2017 - 01/2002
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2016 - 02/2013
2	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 05/2016 - 05/2011
2	Tamoxifen FDA LinkGeneric 02/2015 - 07/2010
2	PlatinumIBA 11/2014 - 04/2010
2	Gemcitabine FDA Link 12/2013 - 05/2008
2	Tyrosine Kinase InhibitorsIBA 03/2013 - 03/2005
2	Bile Acids and Salts (Bile Acids)IBA 10/2012 - 04/2010
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2011 - 07/2010
2	Cadherins (E-Cadherin)IBA 09/2010 - 09/2002
2	beta CateninIBA 07/2010 - 09/2002
2	Caspase 3 (Caspase-3)IBA 07/2010 - 05/2007
2	Caspase 9IBA 07/2010 - 05/2007
2	Acetylcysteine (Siran)FDA LinkGeneric 04/2010 - 05/2007
2	Superoxides (Superoxide)IBA 04/2010 - 05/2007
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2008 - 06/2007
2	Superoxide DismutaseIBA 08/2007 - 05/2007
2	Protein Isoforms (Isoforms)IBA 06/2007 - 09/2006
2	Matrix Metalloproteinases (MMPs)IBA 05/2006 - 08/2004
2	Oleic Acid (Oleate)IBA 12/2004 - 12/2004
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2003 - 09/2003

Therapy/Procedure

12	Therapeutics 09/2023 - 06/2006
9	Drug Therapy (Chemotherapy) 02/2022 - 01/2008
3	Artificial Respiration (Mechanical Ventilation) 12/2021 - 01/2017
2	Gastrectomy 01/2008 - 01/2002